More HeraMED Ltd news
HeraMED LtdASX: HMD

Final Approvals Received to Commence Clinical Study

Jul 12, 2020 at 8:12 PM EDT · Issued by HeraMED Ltd

Filed with ASX · Jul 12, 2020 at 8:12 PM EDT

On 6ix: 6ix.com/news/final-approvals-received-to-commence-clinical-study

Heramed Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

HeraMED Ltd on 6ix

Earlier from HeraMED

  • Company Presentation - June 2020Jun 5, 2020
  • HMD Raises $2.32 Million and Launches SPPJun 4, 2020
  • Agreement with Freeman Rd & PHI Group - Pilots in AustraliaMay 19, 2020
  • Exclusive Agreement Executed with Australian DistributorMay 7, 2020
  • Quarterly Activities and CashFlow ReportApr 30, 2020

Later from HeraMED

  • Results of Share Purchase Plan OfferJul 13, 2020
  • Pause In TradingJul 16, 2020
  • HeraMED Extends its Collaboration with Mayo ClinicJul 20, 2020
  • Updated Quarterly Activities ReportAug 3, 2020
  • Partnership with Leading Virtual Care Platform eCare21 in USSep 15, 2020
All HeraMED news releases↗

Follow HeraMED into a list and get an email when it puts out news.

Follow HeraMED
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer